PAR 12.7% 31.0¢ paradigm biopharmaceuticals limited..

Ann: iPPS Demonstrates Multiple DMOAD Signals in Phase 2 Study, page-226

  1. 596 Posts.
    lightbulb Created with Sketch. 109
    @bobsee - I don't want them aggressively pursuing anything at this point. I just want them to get it right. And I don't think getting it right is going to be easy or quick when you are making medical history in the 21st century.
    Last edited by Babbanap: 11/04/23
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.